Liver Metastases
📧 Sign up to get email alerts when something new happens for Liver Metastases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases [NA]
Completed clinical trial evaluating palliative radiotherapy for symptomatic hepatocellular carcinoma and liver metastases, with results post…
-
CLINICAL_TRIALS trial_result · 2024-08-19Clinical Trial Update: The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/UK) [NA]
This clinical trial update reports on the HistoSonics System using histotripsy for treating liver tumors, including hepatocellular carcinoma…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases
A completed clinical trial from Peking University Cancer Hospital & Institute evaluating dynamic ctDNA detection for colorectal cancer with …
-
CLINICAL_TRIALS trial_result · 2024-04-11Clinical Trial Update: The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy [NA]
Results from the HistoSonics histotripsy system trial for liver tumors have been posted. The study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases [Phase 2, Phase 3]
A Phase 2/Phase 3 trial investigating RC48-ADC given IV in HER2-positive metastatic breast cancer, with or without liver metastases.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases [Phase 1, Phase 2]
Phase 1/2 clinical trial investigating hyperthermia combined with immunotherapy for abdominal and pelvic cancers and metastases; trial compl…
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Toripalimab,Celecoxib and Regorafenib in the Treatment of Refractory Advanced Colorectal Cancer [Phase 2]
Phase 2 clinical trial evaluating toripalimab combined with celecoxib and regorafenib for refractory advanced colorectal cancer with liver m…
-
CLINICAL_TRIALS trial_result · 2024-01-22Clinical Trial Update: Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM [Phase 3]
Phase 3 trial investigating adjuvant systemic chemotherapy with or without HAI-FUDR in patients with resected colorectal liver metastases; s…
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease [Phase 2]
Phase 2 clinical trial evaluating intra-hepatic chemotherapy for liver metastases from breast cancer with limited extrahepatic disease has c…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence [Phase 2]
Phase 2 trial evaluating postoperative chemotherapy with or without radiotherapy and immunotherapy for colorectal liver metastases at high r…
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver [Phase 2]
A Phase 2 trial examining isolated hepatic perfusion with melphalan followed by chemotherapy in patients with unresectable colorectal cancer…
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: Low Dose ICG for Biliary Tract and Tumor Imaging [Phase 2]
Phase 2 trial evaluating low-dose indocyanine green (ICG) for biliary tract and tumor imaging completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM [Phase 3]
A Phase 3 trial comparing cetuximab plus mFOLFOX6 versus mFOLFOX6 alone in patients with RAS/BRAF wild-type, high-risk resectable colorectal…
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: Serplulimab+Regorafenib +Hepatic Artery Bicarbonate Infusion in Patients With Colorectal Cancer and Liver Metastases [Phase 2]
A Phase 2 clinical trial evaluating serplulimab combined with regorafenib and hepatic artery bicarbonate infusion for colorectal cancer with…
-
CLINICAL_TRIALS trial_result · 2023-05-17Clinical Trial Update: COLLISION RELAPSE Trial [Phase 3]
Phase 3 clinical trial update for COLLISION RELAPSE investigating colorectal cancer with liver metastases; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer [Phase 3]
A Phase 3 trial is exploring ctDNA-guided adjuvant chemotherapy for liver metastases arising from colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA [Phase 3]
Phase 3 trial evaluating post-operative maintenance therapy for resectable liver metastases from colorectal cancer guided by ctDNA; currentl…
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation [Phase 2]
Phase 2 trial investigating liver transplantation to improve outcomes in selected patients with non-resectable hepatic metastases from color…
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM [Phase 3]
Phase 3 trial comparing FUDR/Oxaliplatin hepatic arterial infusion plus Irinotecan versus FOLFOXIRI chemotherapy in initially unresectable c…
-
CLINICAL_TRIALS trial_result · 2023-02-15Clinical Trial Update: A Study of Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLM [Phase 2]
Phase 2 trial evaluating systemic chemotherapy CPT-11 with hepatic arterial infusion FUDR+L-OHP for initially unresectable colorectal cancer…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma [Phase 2]
Phase 2 trial investigating recombinant human adenovirus type 5 injection with a PD-1 monoclonal antibody and nab-paclitaxel for liver metas…
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases [Phase 2, Phase 3]
Phase 2/3 trial evaluating tislelizumab in combination with SOX for gastric cancer with liver metastases; status currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Intra-arterial Lutetium-177-dotatate for Treatment of Patients With Neuro-endocrine Tumor Liver Metastases [Phase 2, Phase 3]
A clinical trial update for intra-arterial Lutetium-177-dotatate in neuroendocrine tumor patients with liver metastases (Phase 2 and Phase 3…
-
CLINICAL_TRIALS trial_result · 2022-06-08Clinical Trial Update: Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status [Phase 2, Phase 3]
An exploratory Phase 2/3 clinical trial evaluating combined conversion immunotherapy for liver metastases from unresectable MSS-type colorec…
-
CLINICAL_TRIALS trial_result · 2022-06-06Clinical Trial Update: Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line Therapy [Phase 2]
Phase 2 trial update evaluating hepatic arterial infusion chemotherapy with Fruquintinib as third-line therapy for colorectal cancer with li…